Measles Overview
Learn About Measles
Measles is a very contagious (easily spread) illness caused by a virus.
Rubeola
Measles is spread by contact with droplets from the nose, mouth, or throat of an infected person. Sneezing and coughing can put contaminated droplets into the air.
If one person has the measles, 90% of the people who come in contact with that person will get the measles, unless they have been vaccinated.
People who had measles or who have been vaccinated against measles are protected from the disease. As of 2000, measles had been eliminated in the United States. However, unvaccinated people who travel to other countries where measles is common have brought the disease back to the United States. This has led to recent outbreaks of measles in groups of people who are unvaccinated.
Some parents do not let their children get vaccinated. This is because of unfounded fears that the MMR vaccine, which protects against measles, mumps, and rubella, can cause autism. Parents and caregivers should know that:
- Large studies of thousands of children have found no connection between this or any vaccine and autism.
- Reviews by all major health organizations in the United States, Great Britain, and elsewhere all found no link between the MMR vaccine and autism.
- The study that had first reported a risk of autism from this vaccine has been proven to be fraudulent.
Symptoms of measles usually begin 10 to 14 days after exposure to the virus. This is called the incubation period.
Rash is often the main symptom. The rash:
- Usually appears 3 to 5 days after the first signs of being sick
- May last 4 to 7 days
- Usually starts on the head and spreads to other areas, moving down the body
- May appear as flat, discolored areas (macules) and solid, red, raised areas (papules) that later join together
- Itches
Other symptoms may include:
- Bloodshot eyes
- Cough
- Fever
- Light sensitivity (photophobia)
- Muscle pain
- Red and inflamed eyes (conjunctivitis)
- Runny nose
- Sore throat
- Tiny white spots inside the mouth (Koplik spots)
There is no specific treatment for the measles.
The following may relieve symptoms:
- Acetaminophen (Tylenol)
- Bed rest
- Humidified air
Some children may need vitamin A supplements, which reduce the risk of death and complications in children who do not get enough vitamin A.
William Moss is a Pediatrics provider in Baltimore, Maryland. Dr. Moss and is rated as an Elite provider by MediFind in the treatment of Measles. His top areas of expertise are Measles, Rubella, HIV/AIDS, and Childhood Iron Deficiency Anemia.
Jon Andrus is a Family Medicine provider in Washington, Washington, D.c.. Dr. Andrus and is rated as a Distinguished provider by MediFind in the treatment of Measles. His top areas of expertise are Togaviridae Disease, Rubella, Measles, and Parainfluenza.
Medical Faculty Associates, Inc
Jonathan Silverberg is a Dermatologist in Washington, Washington, D.c.. Dr. Silverberg has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Measles. His top areas of expertise are Atopic Dermatitis, Stasis Dermatitis and Ulcers, Contact Dermatitis, and Vitiligo. Dr. Silverberg is currently accepting new patients.
Those who do not have complications such as pneumonia do very well.
Complications of measles infection may include:
- Irritation and swelling of the main passages that carry air to the lungs (bronchitis)
- Diarrhea
- Irritation and swelling of the brain (encephalitis)
- Ear infection (otitis media)
- Pneumonia
Contact your provider if you or your child has symptoms of measles.
Getting vaccinated is a very effective way to prevent measles. People who are not immunized, or who have not received the full immunization, are at high risk of catching the disease if they are exposed.
Taking serum immune globulin within 6 days after being exposed to the virus can reduce the risk of developing measles or make the disease less severe.
Summary: The purpose of this study is to assess how well-tolerated GSK's investigational varicella vaccine (VNS Vaccine) is, in comparison to an already approved varicella vaccine (VV) known as Varivax. The study will be conducted on healthy children aged 12 to 15 months, and who have neither contracted varicella nor received a varicella vaccination.
Summary: The goal of this observational study is to investigate the effects of measles virus (MeV) infection on pre-existing immunity, vaccine response, and susceptibility to subsequent illness in children aged 1-15 either with or without acute MeV infection.
Published Date: July 16, 2024
Published By: Neil K. Kaneshiro, MD, MHA, Clinical Professor of Pediatrics, University of Washington School of Medicine, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Centers for Disease Control and Prevention website. Measles (rubeola). www.cdc.gov/measles/about/index.html. Updated May 29, 2024. Accessed July 17, 2024.
Cherry JD, Lugo D. Measles virus. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier; 2019:chap 180.
Maldonado YA, Shetty AK. Rubeola virus: measles and subacute sclerosing panencephalitis. In: Long SS, Prober CG, Fischer M, Kimberlin DW, eds. Principles and Practice of Pediatric Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 227.